Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 307, pseudogene (RN7SL307P)

Target: RN7SL307P
Molecular classification: Other (Pseudogene), Noncoding RNA (ncRNA) pseudogene

Overview

RN7SL307P (RNA, 7SL, cytoplasmic 307, pseudogene) is a human noncoding RNA pseudogene belonging to the 7SL RNA family[1][6]. Pseudogenes in this family typically arise from reverse transcription of functional 7SL RNA, which is a component of the signal recognition particle (SRP)[3][4][5]. Unlike functional 7SL RNA, which is essential for protein translocation and various cellular processes, pseudogenes like RN7SL307P do not encode functional RNA or protein and are not expressed[3][4][6]. They do NOT participate in biological activity, disease processes, or serve as drug targets. Most 7SL pseudogenes are truncated and nonfunctional[3][4]. The parent 7SL RNA has critical functions in translation and cell biology[5][7], but this does NOT apply to RN7SL307P, which is an inactive genomic remnant.

Other names: RN7SL307PRNA, 7SL, cytoplasmic 307, pseudogene

Mechanism of action

Not applicable.

Biological functions

None specified (as a pseudogene, it does NOT have a documented biological function)

Disease associations

None — There is no evidence or documentation of a direct role in disease for this specific pseudogene

Safety considerations

None — There are no known safety concerns since it is not targeted therapeutically

Interacting drugs

None — There are no drugs reported to interact with RN7SL307P

Biomarkers

None — This pseudogene is not used as a biomarker for disease or therapy

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 307, pseudogene (RN7SL307P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 307, pseudogene (RN7SL307P).

Explore the full profile